{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:52:51Z","timestamp":1791287571141,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2018YFA0107500"],"award-info":[{"award-number":["2018YFA0107500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhenjiang Social Development Fund","award":["SH2020027"],"award-info":[{"award-number":["SH2020027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mesenchymal stem cells (MSCs) are considered to be a potential therapeutic tool for liver fibrosis. Inhibiting the activation of hepatic stellate cells (HSCs) and protecting hepatocytes are important mechanisms for the anti-fibrotic effect of MSCs. However, how MSCs inhibit liver fibrosis by regulating the expression of microRNAs (miRNAs) has not been fully clarified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Transforming growth factor-\u03b21 (TGF-\u03b21)-activated HSCs LX-2 were single cultured or co-cultured with human umbilical cord mesenchymal stem cells (HUC-MSCs). High-throughput sequencing was used to evaluate the differentially expressed microRNAs (DEMs) between the two groups. Quantitative real-time PCR (qRT-PCR), Western blot, and transfection experiments were used to investigate and screen the most significantly up-regulated DEM. Bioinformatics analysis was used to predict the target mRNAs and the potential functions of the DEM. The possible mechanism of HUC-MSCs against liver fibrosis was analyzed by co-culture experiment of HUC-MSCs with LX-2 cells, and HUC-MSCs treatment of Bile duct ligation (BDL)-induced liver fibrosis in mice. Finally, the mechanism of the DEM regulating liver fibrosis was confirmed in human liver fibrosis specimens.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MicroRNA-148a-5p (miR-148a-5p) was the most significantly up-regulated DEM in activated LX-2 cells co-cultured with HUC-MSCs compared with LX-2 cells single cultured. Up-regulation of the expression of miR-148a-5p in activated LX-2 cells could significantly inhibit the expression of hepatic fibrosis markers \u03b1-SMA and Col1\u03b11. Notch2 was one target gene of miR-148a-5p. Co-cultured with HUC-MSCs could inhibit the activation of LX-2 cells by inhibiting the expression of the Notch2 and the Notch signaling pathway. In addition, HUC-MSCs treatment could up-regulate the expression of miR-148a-5p in liver tissue and hepatocytes, promote the proliferation and avoid the apoptosis of hepatocytes, and reduce the degree of fibrosis by inhibiting expression of the Notch2 and the Notch signaling pathway in BDL-induced liver fibrosis mice. Moreover, miR-148a-5p was down-regulated and Notch2 was up-regulated in fibrotic human liver tissues compared with the normal livers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>HUC-MSCs treatment could inhibit HSCs activation, protect hepatocytes, and alleviate BDL-induced liver fibrosis in mice by up-regulating the expression of miR-148-5p and inhibiting the Notch signaling pathway. The down-regulation of miR-148-5p and up-regulation of Notch2 could be used as biomarkers to monitor the progression of liver fibrosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-022-03030-8","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T13:48:54Z","timestamp":1658929734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway"],"prefix":"10.1186","volume":"13","author":[{"given":"Qing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongda","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zhuansun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuorun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanrong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6582-0726","authenticated-orcid":false,"given":"Shouli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"3030_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37\u201355. https:\/\/doi.org\/10.1016\/j.mam.2018.09.002.","journal-title":"Mol Aspects Med"},{"issue":"7","key":"3030_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397\u2013411. https:\/\/doi.org\/10.1038\/nrgastro.2017.38.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"3030_CR3","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/cphy.c120035","volume":"3","author":"JE Puche","year":"2013","unstructured":"Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3(4):1473\u201392. https:\/\/doi.org\/10.1002\/cphy.c120035.","journal-title":"Compr Physiol"},{"issue":"3","key":"3030_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18(3):151\u201366. https:\/\/doi.org\/10.1038\/s41575-020-00372-7.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3030_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27\u201342. https:\/\/doi.org\/10.1016\/j.addr.2017.05.007.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"3030_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.stem.2017.07.011","volume":"21","author":"E El Agha","year":"2017","unstructured":"El Agha E, Kramann R, Schneider RK, Li X, Seeger W, Humphreys BD, et al. Mesenchymal stem cells in fibrotic disease. Cell Stem Cell. 2017;21(2):166\u201377. https:\/\/doi.org\/10.1016\/j.stem.2017.07.011.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3030_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13287-018-0814-4","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Li Y, Zhang L, Li J, Zhu C. Mesenchymal stem cells: potential application for the treatment of hepatic cirrhosis. Stem Cell Res Ther. 2018;9(1):59. https:\/\/doi.org\/10.1186\/s13287-018-0814-4.","journal-title":"Stem Cell Res Ther"},{"key":"3030_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12334","author":"F Hendijani","year":"2017","unstructured":"Hendijani F. Explant culture: An advantageous method for isolation of mesenchymal stem cells from human tissues. Cell Prolif. 2017. https:\/\/doi.org\/10.1111\/cpr.12334.","journal-title":"Cell Prolif"},{"key":"3030_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030708","author":"DT Chu","year":"2020","unstructured":"Chu DT, Phuong TNT, Tien NLB, Tran DK, Thanh VV, Quang TL, et al. An update on the progress of isolation, culture, storage, and clinical application of human bone marrow mesenchymal stem\/stromal cells. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21030708.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3030_CR10","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/stem.1681","volume":"32","author":"FJ Lv","year":"2014","unstructured":"Lv FJ, Tuan RS, Cheung KM, Leung VY. Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells. 2014;32(6):1408\u201319. https:\/\/doi.org\/10.1002\/stem.1681.","journal-title":"Stem Cells"},{"issue":"1","key":"3030_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/nyas.13102","volume":"1370","author":"H Li","year":"2016","unstructured":"Li H, Ghazanfari R, Zacharaki D, Lim HC, Scheding S. Isolation and characterization of primary bone marrow mesenchymal stromal cells. Ann N Y Acad Sci. 2016;1370(1):109\u201318. https:\/\/doi.org\/10.1111\/nyas.13102.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"3030_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/sctm.18-0105","volume":"8","author":"Y Watanabe","year":"2019","unstructured":"Watanabe Y, Tsuchiya A, Seino S, Kawata Y, Kojima Y, Ikarashi S, et al. Mesenchymal stem cells and induced bone marrow-derived macrophages synergistically improve liver fibrosis in mice. Stem Cells Transl Med. 2019;8(3):271\u201384. https:\/\/doi.org\/10.1002\/sctm.18-0105.","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"3030_CR13","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1053\/j.gastro.2016.12.003","volume":"152","author":"SY An","year":"2017","unstructured":"An SY, Jang YJ, Lim HJ, Han J, Lee J, Lee G, et al. milk fat globule-EGF Factor 8, secreted by mesenchymal stem cells, protects against liver fibrosis in mice. Gastroenterology. 2017;152(5):1174\u201386. https:\/\/doi.org\/10.1053\/j.gastro.2016.12.003.","journal-title":"Gastroenterology"},{"issue":"1","key":"3030_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13287-017-0575-5","volume":"8","author":"M Najimi","year":"2017","unstructured":"Najimi M, Berardis S, El-Kehdy H, Rosseels V, Evraerts J, Lombard C, et al. Human liver mesenchymal stem\/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation. Stem Cell Res Ther. 2017;8(1):131. https:\/\/doi.org\/10.1186\/s13287-017-0575-5.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"3030_CR15","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/hep.28693","volume":"64","author":"KT Suk","year":"2016","unstructured":"Suk KT, Yoon JH, Kim MY, Kim CW, Kim JK, Park H, et al. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: phase 2 trial. Hepatology. 2016;64(6):2185\u201397. https:\/\/doi.org\/10.1002\/hep.28693.","journal-title":"Hepatology"},{"issue":"1","key":"3030_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2017.09.049","volume":"154","author":"CW Lee","year":"2018","unstructured":"Lee CW, Chen YF, Wu HH, Lee OK. Historical perspectives and advances in mesenchymal stem cell research for the treatment of liver diseases. Gastroenterology. 2018;154(1):46\u201356. https:\/\/doi.org\/10.1053\/j.gastro.2017.09.049.","journal-title":"Gastroenterology"},{"issue":"1","key":"3030_CR17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1182\/blood-2007-03-078774","volume":"111","author":"PS Cho","year":"2008","unstructured":"Cho PS, Messina DJ, Hirsh EL, Chi N, Goldman SN, Lo DP, et al. Immunogenicity of umbilical cord tissue derived cells. Blood. 2008;111(1):430\u20138. https:\/\/doi.org\/10.1182\/blood-2007-03-078774.","journal-title":"Blood"},{"issue":"1","key":"3030_CR18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s13287-021-02468-6","volume":"12","author":"Y He","year":"2021","unstructured":"He Y, Guo X, Lan T, Xia J, Wang J, Li B, et al. Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1\/Stat3 signaling. Stem Cell Res Ther. 2021;12(1):396. https:\/\/doi.org\/10.1186\/s13287-021-02468-6.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3030_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13287-019-1184-2","volume":"10","author":"G Guo","year":"2019","unstructured":"Guo G, Zhuang X, Xu Q, Wu Z, Zhu Y, Zhou Y, et al. Peripheral infusion of human umbilical cord mesenchymal stem cells rescues acute liver failure lethality in monkeys. Stem Cell Res Ther. 2019;10(1):84. https:\/\/doi.org\/10.1186\/s13287-019-1184-2.","journal-title":"Stem Cell Res Ther"},{"issue":"6230","key":"3030_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1126\/science.aaa1738","volume":"348","author":"JM Schmiedel","year":"2015","unstructured":"Schmiedel JM, Klemm SL, Zheng Y, Sahay A, Bluthgen N, Marks DS, et al. Gene expression. MicroRNA control of protein expression noise. Science. 2015;348(6230):128\u201332. https:\/\/doi.org\/10.1126\/science.aaa1738.","journal-title":"Science"},{"issue":"4","key":"3030_CR21","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","volume":"70","author":"X Wang","year":"2021","unstructured":"Wang X, He Y, Mackowiak B, Gao B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut. 2021;70(4):784\u201395. https:\/\/doi.org\/10.1136\/gutjnl-2020-322526.","journal-title":"Gut"},{"key":"3030_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.trsl.2019.07.007","volume":"214","author":"Z Zhao","year":"2019","unstructured":"Zhao Z, Lin CY, Cheng K. siRNA- and miRNA-based therapeutics for liver fibrosis. Transl Res. 2019;214:17\u201329. https:\/\/doi.org\/10.1016\/j.trsl.2019.07.007.","journal-title":"Transl Res"},{"issue":"3","key":"3030_CR23","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/hep.28367","volume":"63","author":"KH Jung","year":"2016","unstructured":"Jung KH, Zhang J, Zhou C, Shen H, Gagea M, Rodriguez-Aguayo C, et al. Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis. Hepatology. 2016;63(3):864\u201379. https:\/\/doi.org\/10.1002\/hep.28367.","journal-title":"Hepatology"},{"issue":"4","key":"3030_CR24","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1136\/gutjnl-2017-315123","volume":"68","author":"MJ Heo","year":"2019","unstructured":"Heo MJ, Kim TH, You JS, Blaya D, Sancho-Bru P, Kim SG. Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression. Gut. 2019;68(4):708\u201320. https:\/\/doi.org\/10.1136\/gutjnl-2017-315123.","journal-title":"Gut"},{"issue":"7","key":"3030_CR25","doi-asserted-by":"publisher","first-page":"e2916","DOI":"10.1038\/cddis.2017.309","volume":"8","author":"L Cheng","year":"2017","unstructured":"Cheng L, Zhu Y, Han H, Zhang Q, Cui K, Shen H, et al. MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice. Cell Death Dis. 2017;8(7):e2916. https:\/\/doi.org\/10.1038\/cddis.2017.309.","journal-title":"Cell Death Dis"},{"issue":"10","key":"3030_CR26","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.7150\/jca.14616","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Deng X, Zeng X, Peng X. The role of Mir-148a in cancer. J Cancer. 2016;7(10):1233\u201341. https:\/\/doi.org\/10.7150\/jca.14616.","journal-title":"J Cancer"},{"issue":"9","key":"3030_CR27","first-page":"2569","volume":"5","author":"XY Liu","year":"2015","unstructured":"Liu XY, He YJ, Yang QH, Huang W, Liu ZH, Ye GR, et al. Induction of autophagy and apoptosis by miR-148a through the sonic hedgehog signaling pathway in hepatic stellate cells. Am J Cancer Res. 2015;5(9):2569\u201389.","journal-title":"Am J Cancer Res"},{"issue":"7","key":"3030_CR28","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41418-017-0006-2","volume":"25","author":"G Wang","year":"2018","unstructured":"Wang G, Cao K, Liu K, Xue Y, Roberts AI, Li F, et al. Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells. Cell Death Differ. 2018;25(7):1209\u201323. https:\/\/doi.org\/10.1038\/s41418-017-0006-2.","journal-title":"Cell Death Differ"},{"issue":"1","key":"3030_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13287-018-1102-z","volume":"10","author":"X Li","year":"2019","unstructured":"Li X, Shang B, Li YN, Shi Y, Shao C. IFNgamma and TNFalpha synergistically induce apoptosis of mesenchymal stem\/stromal cells via the induction of nitric oxide. Stem Cell Res Ther. 2019;10(1):18. https:\/\/doi.org\/10.1186\/s13287-018-1102-z.","journal-title":"Stem Cell Res Ther"},{"key":"3030_CR30","doi-asserted-by":"publisher","first-page":"963689721100001","DOI":"10.1177\/09636897211000014","volume":"30","author":"K Shibuya","year":"2021","unstructured":"Shibuya K, Watanabe M, Goto R, Zaitsu M, Ganchiku Y, Taketomi A. The efficacy of the hepatocyte spheroids for hepatocyte transplantation. Cell Transpl. 2021;30:9636897211000014. https:\/\/doi.org\/10.1177\/09636897211000014.","journal-title":"Cell Transpl"},{"issue":"6","key":"3030_CR31","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jhep.2008.08.011","volume":"49","author":"P Nahon","year":"2008","unstructured":"Nahon P, Kettaneh A, Tengher-Barna I, Ziol M, de Ledinghen V, Douvin C, et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol. 2008;49(6):1062\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2008.08.011.","journal-title":"J Hepatol"},{"key":"3030_CR32","doi-asserted-by":"publisher","first-page":"6685605","DOI":"10.1155\/2021\/6685605","volume":"2021","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Gu T, Zhang Y, Li H, Zhuansun X, Xu S, et al. Human umbilical cord mesenchymal stem cells ameliorate hepatic stellate cell activation and liver fibrosis by upregulating MicroRNA-455\u20133p through suppression of p21-activated kinase-2. Biomed Res Int. 2021;2021:6685605. https:\/\/doi.org\/10.1155\/2021\/6685605.","journal-title":"Biomed Res Int"},{"key":"3030_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071723","author":"J Baglieri","year":"2019","unstructured":"Baglieri J, Brenner DA, Kisseleva T. The role of fibrosis and liver-associated fibroblasts in the pathogenesis of hepatocellular carcinoma. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20071723.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"3030_CR34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s40265-019-01126-9","volume":"79","author":"P Manka","year":"2019","unstructured":"Manka P, Zeller A, Syn WK. Fibrosis in chronic liver disease: an update on diagnostic and treatment modalities. Drugs. 2019;79(9):903\u201327. https:\/\/doi.org\/10.1007\/s40265-019-01126-9.","journal-title":"Drugs"},{"issue":"12","key":"3030_CR35","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1096\/fj.201600433R","volume":"30","author":"D Haldar","year":"2016","unstructured":"Haldar D, Henderson NC, Hirschfield G, Newsome PN. Mesenchymal stromal cells and liver fibrosis: a complicated relationship. FASEB J. 2016;30(12):3905\u201328. https:\/\/doi.org\/10.1096\/fj.201600433R.","journal-title":"FASEB J"},{"issue":"12","key":"3030_CR36","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/eji.201747132","volume":"47","author":"M Friedrich","year":"2017","unstructured":"Friedrich M, Pracht K, Mashreghi MF, Jack HM, Radbruch A, Seliger B. The role of the miR-148\/-152 family in physiology and disease. Eur J Immunol. 2017;47(12):2026\u201338. https:\/\/doi.org\/10.1002\/eji.201747132.","journal-title":"Eur J Immunol"},{"issue":"6","key":"3030_CR37","doi-asserted-by":"publisher","first-page":"9698","DOI":"10.1002\/jcp.27656","volume":"234","author":"J Zhu","year":"2019","unstructured":"Zhu J, Luo Z, Pan Y, Zheng W, Li W, Zhang Z, et al. H19\/miR-148a\/USP4 axis facilitates liver fibrosis by enhancing TGF-beta signaling in both hepatic stellate cells and hepatocytes. J Cell Physiol. 2019;234(6):9698\u2013710. https:\/\/doi.org\/10.1002\/jcp.27656.","journal-title":"J Cell Physiol"},{"issue":"3","key":"3030_CR38","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/hep.26422","volume":"58","author":"L Gailhouste","year":"2013","unstructured":"Gailhouste L, Gomez-Santos L, Hagiwara K, Hatada I, Kitagawa N, Kawaharada K, et al. miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells. Hepatology. 2013;58(3):1153\u201365. https:\/\/doi.org\/10.1002\/hep.26422.","journal-title":"Hepatology"},{"issue":"1","key":"3030_CR39","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13046-020-01649-0","volume":"39","author":"Z Huang","year":"2020","unstructured":"Huang Z, Wen J, Yu J, Liao J, Liu S, Cai N, et al. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner. J Exp Clin Cancer Res. 2020;39(1):150. https:\/\/doi.org\/10.1186\/s13046-020-01649-0.","journal-title":"J Exp Clin Cancer Res"},{"key":"3030_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev-pathol-052016-100127","volume":"12","author":"JC Aster","year":"2017","unstructured":"Aster JC, Pear WS, Blacklow SC. The varied roles of notch in cancer. Annu Rev Pathol. 2017;12:245\u201375. https:\/\/doi.org\/10.1146\/annurev-pathol-052016-100127.","journal-title":"Annu Rev Pathol"},{"issue":"9","key":"3030_CR41","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.7150\/ijbs.60056","volume":"17","author":"Z Yue","year":"2021","unstructured":"Yue Z, Jiang Z, Ruan B, Duan J, Song P, Liu J, et al. Disruption of myofibroblastic Notch signaling attenuates liver fibrosis by modulating fibrosis progression and regression. Int J Biol Sci. 2021;17(9):2135\u201346. https:\/\/doi.org\/10.7150\/ijbs.60056.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3030_CR42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41467-017-00204-4","volume":"8","author":"K Zhang","year":"2017","unstructured":"Zhang K, Han X, Zhang Z, Zheng L, Hu Z, Yao Q, et al. The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFbeta and Notch pathways. Nat Commun. 2017;8(1):144. https:\/\/doi.org\/10.1038\/s41467-017-00204-4.","journal-title":"Nat Commun"},{"issue":"3","key":"3030_CR43","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3748\/wjg.v21.i3.878","volume":"21","author":"K Zhang","year":"2015","unstructured":"Zhang K, Zhang YQ, Ai WB, Hu QT, Zhang QJ, Wan LY, et al. Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-beta\/BMP signaling. World J Gastroenterol. 2015;21(3):878\u201387. https:\/\/doi.org\/10.3748\/wjg.v21.i3.878.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"3030_CR44","doi-asserted-by":"publisher","first-page":"6878","DOI":"10.1021\/acsnano.0c01007","volume":"14","author":"LR Richter","year":"2020","unstructured":"Richter LR, Wan Q, Wen D, Zhang Y, Yu J, Kang JK, et al. Targeted delivery of notch inhibitor attenuates obesity-induced glucose intolerance and liver fibrosis. ACS Nano. 2020;14(6):6878\u201386. https:\/\/doi.org\/10.1021\/acsnano.0c01007.","journal-title":"ACS Nano"},{"issue":"11","key":"3030_CR45","doi-asserted-by":"publisher","first-page":"e13126","DOI":"10.1111\/cpr.13126","volume":"54","author":"T Foroutan","year":"2021","unstructured":"Foroutan T, Kassaee MZ, Salari M, Ahmady F, Molavi F, Moayer F. Magnetic Fe3 O4 @graphene oxide improves the therapeutic effects of embryonic stem cells on acute liver damage. Cell Prolif. 2021;54(11):e13126. https:\/\/doi.org\/10.1111\/cpr.13126.","journal-title":"Cell Prolif"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03030-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-022-03030-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03030-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T13:57:14Z","timestamp":1658930234000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-022-03030-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3030"],"URL":"https:\/\/doi.org\/10.1186\/s13287-022-03030-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"assertion":[{"value":"17 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study protocols were approved by the Jiangsu University Institutional Animal Care and Use Committee (protocol code: UJS-IACUC-2021032302). Procedures for handling the human samples were approved by the Scientific Research Ethics Committee of Affiliated Hospital of Jiangsu University (protocol code: KY2022K0103).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"354"}}